The generic name for metoprolol succinate is metoprolol succinate. It is marketed under various brand names, including Toprol-XL [1].
What is metoprolol succinate used for?
Metoprolol succinate is a beta-blocker medication prescribed to treat high blood pressure and to prevent chest pain (angina) [1]. It works by relaxing blood vessels and slowing the heart rate, which helps to lower blood pressure and reduce the heart's workload [1].
When does metoprolol succinate patent exclusivity expire?
Drug patent information, including expiry dates, can be complex and subject to challenges. For detailed and up-to-date information on metoprolol succinate patent exclusivity, consulting specialized resources is recommended [2]. DrugPatentWatch.com provides comprehensive data on drug patents and their expiration timelines [2].
How does metoprolol succinate compare to metoprolol tartrate?
Metoprolol succinate and metoprolol tartrate are both forms of metoprolol, but they differ in their formulation and how they are released in the body. Metoprolol succinate is an extended-release formulation, meaning it is designed to release the medication slowly over a longer period, typically taken once a day. Metoprolol tartrate is an immediate-release formulation, usually taken multiple times a day [1]. This difference in release affects dosing schedules and how consistently the drug level is maintained in the body.
What are the potential side effects of metoprolol succinate?
Common side effects of metoprolol succinate can include tiredness, dizziness, slow heart rate, and shortness of breath [1]. Less common side effects may also occur. Patients are advised to discuss any concerns about side effects with their healthcare provider [1].
Can other companies make generic versions of metoprolol succinate?
Once patent exclusivity expires and regulatory hurdles are cleared, other pharmaceutical companies can manufacture and market generic versions of metoprolol succinate. This often leads to increased competition and potentially lower prices for the medication.
What are the regulatory approvals for metoprolol succinate?
Metoprolol succinate is approved by regulatory agencies like the U.S. Food and Drug Administration (FDA) for its indicated uses. Generic versions must also meet stringent FDA standards for safety, efficacy, and quality before they can be approved and marketed [1].
How is metoprolol succinate prescribed and dosed?
Dosage for metoprolol succinate varies depending on the condition being treated and the individual patient's response. It is typically taken orally, once daily, with or without food. Healthcare providers determine the appropriate dose and frequency [1].
*
**Sources:
[1] https://www.drugs.com/metoprolol_succinate.html
[2] https://drugpatentwatch.com/